Predictive MGMT status in a homogeneous cohort of IDH wildtype glioblastoma patients

0

Methylation of the O(6)-Methylguanine-DNA methyltransferase (MGMT) promoter is predictive for treatment response in glioblastoma patients. However, precise predictive cutoff values to distinguish “MGMT methylated…

Read More...

Leave A Reply